Transaction in Own Shares

Summary by AI BETAClose X

WORLDWIDE HEALTHCARE TRUST PLC announced on 5 November 2025 a market purchase of 2,889,493 Ordinary shares, each valued at 2.5p, at a price of 359.6 pence per share. These shares, acquired under authority granted on 1 October 2025 for up to 61,086,622 shares, will be held in treasury. Following this transaction, the company now holds 207,763,146 Ordinary shares in treasury, with 601,665,200 Ordinary shares remaining in issue. Consequently, the total number of voting rights in the company stands at 393,902,054, a figure important for shareholders determining disclosure obligations. This share repurchase activity typically aims to enhance shareholder value by reducing the number of outstanding shares.

Disclaimer*

 

For immediate release

5 November 2025

 

WORLDWIDE HEALTHCARE TRUST PLC

(the "Company")

 

 

MARKET PURCHASE OF COMPANY'S OWN SHARES

 

 

 

This notification is given, pursuant to the authority granted at a General Meeting of the Company held on 1 October 2025 to make market purchases of the Company's own shares up to an aggregate maximum of 61,086,622.

 

The Company has purchased a market total of 2,889,493 Ordinary shares of 2.5p each in the capital of the Company today at a price of 359.6 pence per share. These shares will be held in treasury.

 

Following this transaction, the Company hereby notifies the market that the resultant number of Ordinary shares held by the Company in treasury is 207,763,146 and the total number of Ordinary shares that the Company has in issue is 601,665,200 so that the total number of voting rights in the Company following the repurchase is 393,902,054.

 

The figure of 393,902,054 may be used by shareholders as the denominator for the calculation by which they may determine if they are required to notify their interest in, or change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

 

 

For and on behalf of

Frostrow Capital LLP

Company Secretary

 

For further information, please contact:

 

Mark Pope

Frostrow Capital LLP

Tel: 020 3 0084913

 




UK 100

Latest directors dealings